当前位置：
X-MOL 学术
›
Expert Rev. Pharmacoecon. Outcomes Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cost-effectiveness analysis of toripalimab plus chemotherapy for patients with advanced esophageal squamous cell carcinoma in China
Expert Review of Pharmacoeconomics & Outcomes Research ( IF 2.3 ) Pub Date : 2024-01-25 , DOI: 10.1080/14737167.2023.2270159 Shuo Kang 1 , Xiaohui Wang 2 , Zhenhua Pan 3 , Huanlong Liu 1
Expert Review of Pharmacoeconomics & Outcomes Research ( IF 2.3 ) Pub Date : 2024-01-25 , DOI: 10.1080/14737167.2023.2270159 Shuo Kang 1 , Xiaohui Wang 2 , Zhenhua Pan 3 , Huanlong Liu 1
Affiliation
The aim of the current analysis was to evaluate the cost-effectiveness of toripalimab plus chemotherapy compared with chemotherapy alone as the first-line option for patients with advanced esophage...
更新日期：2024-01-25
京公网安备 11010802027423号